HH Healthcare Successfully Hosts National Distributor Conference for C-Wave® Coronary Intravascular Lithotripsy System

July 4, HuiHe HealthcareC-Wave^®Coronary Shock Wave System China Distributor Meeting Successfully Held in Shanghai!This conference brought together more than 200 dealer partners in the field of cardiac intervention from all over China, jointly witnessing C-Wave.^®The Grand Launch of the Coronary Shockwave System: A New Chapter in Collaboration for Coronary Vascular Intervention

General Manager of ZhongHui Healthcare (a wholly-owned subsidiary of HuiHe Healthcare)Mr. Zengbing ChengWas the first to introduce C-Wave^®The Mental Journey of Product Development: From the Early StagesUnderstandToIVL Products, focusing on the application ofTechnical Principles, Process OptimizationAndClinical Exploration,To determine the R&D direction,Confirm one by oneEffectiveness and Safety of Each Functional Module，To the EndLanding asThe only one with coronary and peripheral indicationsMade in ChinaShock WaveBalloon、At the same timeWith full independent intellectual property rights. Currently,C-Wave^®Applied for 50+ IVL patents, including 30+ invention patents, with a strategic patent layout.InInternational First Tier。

Afterward, the marketing department provided an in-depth explanation of C-Wave.^®Product Features and Clinical Effects of Coronary Shockwave Catheters, EspeciallyA global firstS-shaped spiral electrode arrangement design、As many as320 unitsShock Wave Release Capability，Performance of uniform energy release along the long and short axesIn short, HuiHe Healthcare has provided a user-friendly and highly effective lumen preparation balloon for clinical use.

C-Wave^®The coronary shock wave system has presented impressive data from pre-market clinical studies as well as post-market commercialization strategies.Patient-centered, evidence-basedThe characteristics were thoroughly understood by the dealer partners during the meeting.C-Wave^®Post-marketing Clinical Trials,MedCalcium China Tour Academic Session and IVL Combined Volume Reduction Comprehensive Training CourseThe plan, these introductions have enabled all the dealer partners to understand C-Wave more profoundly.^®The academic promotion approach, and more recognition of HuiHe Healthcare's simple idea of providing good products for clinical use.

CTO of HuiHe HealthcareMr. Xu JunShared with the conference the complete product pipeline and core product R&D progress of HuiHe Healthcare.

The continuous launch of innovative products by HuiHe Healthcare stems from the company's culture of innovation, which drives the relentless pursuit of cutting-edge technologies and the constant overcoming of technical challenges. The pipeline layout of HuiHe Healthcare is closely aligned with the goal of providing comprehensive solutions in the field of vascular intervention.The product pipeline is divided into four major segments: structural heart disease, vascular intervention, oncology intervention, and intelligent intervention.Among them, the vascular intervention and tumor intervention lines includeCoronary and peripheral shock wave catheters, visible drug-eluting embolic microspheres, etc.;Structural Heart Disease Pipeline IncludesStructural Heart K-Clip^®Transcatheter Tricuspid Annuloplasty System, L-Clip Mitral Annuloplasty SystemSuch products. In addition to the five commercialized products that have already obtained certification, there are currently nearly 20 products under research and development. A total of nearly 300 invention patents have been published, and nearly 100 invention patents have already been granted.

Subsequently, the Medical DepartmentManager Ye Zhouzhou, introduced in detailK-Clip^®Transcatheter Tricuspid Plasty SystemThis product is the fastest progressing product in the field of structural heart disease by HuiHe Healthcare.K-Clip^®is a classic surgical reductionRingVascular Pathway Devices for Surgical Procedures, which originally required open-chest surgery, can now be performed through vascular puncture, featuring minimal trauma, quick recovery, good results, and simple operation. The average operation time is only 30 minutes, with the advantages of "Safe, Effective, Flexible Strategy"The product has accumulated over 300 clinical cases and has been widely applied in overseas markets such as the United States, Canada, France, and Spain.Recognized by world-renowned structural heart experts。

Head of Clinical Department, HuiHe HealthcareMs. Chen Yang, introduced the pre-market clinical research status of the full range of products. HuiHe HealthcareWith a rigorous clinical research plan,Detailed experimental data provides strong evidence for the safety and effectiveness of the product.. Meanwhile, Ms. Chen Yang also announced C-Wave for the first time at the conference.^®The post-marketing clinical plan for the coronary shock wave system demonstrates the sincerity of HuiHe Healthcare's collaboration with its distributor partners.

Head of HuiHe Healthcare Operations DepartmentMr. Liang TaoAt the conference, HuiHe Healthcare's "Quality Excellence, Patient First" of the company's values. EmphasizingHuiHe Healthcare is a company with a strong sense of social mission.，Implement global-level stringent standards for the quality of all delivered products.The company has undergone more than 10 system audits, with 5 products already certified and commercialized, and a total investment in production reaching 150 million RMB.We insist on producing all our products ourselves, with the aim of delivering higher quality and more stable products to clinical settings.

Finally, HuiHe Healthcare CFO (Chief Financial Officer)Mr. Shen Jianwen, interpreting commercial compliance from the perspective of the overall development of the industry,The fundamental reason for the long-term development of the medical industry lies in the positive cycle of technological innovation and commercial feedback.. And pointed out that HuiHe Healthcare wouldContinuously pursue a technology-driven path`, providing more high-quality and fairly-priced medical products for doctors and frontline clinical staff.`

Distributor partners actively participated in on-site interactions during the relaxed and open meeting, creating a warm and harmonious atmosphere.

During the exhibition of HuiHe Healthcare's full product line, dealers were able to experience the products on-site and engage in lively discussions. After experiencing the products, the dealers expressed admiration for the advanced technology of HuiHe Healthcare, the excellent performance of the products, and the professionalism of the staff. They highly recognized the series of products that will be launched in the future and expressed their anticipation to become long-term partners of HuiHe Healthcare!

The conference was successfully held.AnnouncedC-Wave^®Coronary Shockwave System Officially Launched, Steadily Moving Towards Commercialization!

We willContinuously Deepening in the Pan-Vascular Field, alwaysLed by innovation, market-oriented, and technology-driven`, and work together with medical professionals to bring health and hope to patients.`